Covered recipient · General Payments record
JENNIFER DEMPSEY MARTIN
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$3,978.41
- Reported across 258 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $419.12 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $293.52 | 10 |
| Mallinckrodt Hospital Products Inc. | $57.61 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.42 | 1 |
| Abbott Laboratories | $27.40 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $27.40 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124853883 | CMS |
| ABBVIE INC. | $25.16 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104973445 | CMS |
| ABBVIE INC. | $24.74 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104973447 | CMS |
| ABBVIE INC. | $17.64 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104973449 | CMS |
| ABBVIE INC. | $114.84 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104973451 | CMS |
| ABBVIE INC. | $22.80 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104973453 | CMS |
| ABBVIE INC. | $29.11 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104973455 | CMS |
| ABBVIE INC. | $7.04 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104973457 | CMS |
| ABBVIE INC. | $13.22 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104973459 | CMS |
| ABBVIE INC. | $18.41 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104973461 | CMS |
| ABBVIE INC. | $20.56 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104973463 | CMS |
| E.R. Squibb & Sons, L.L.C. | $13.17 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101518448 | CMS |
| Mallinckrodt Hospital Products Inc. | $14.86 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145104352 | CMS |
| Mallinckrodt Hospital Products Inc. | $26.27 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145104357 | CMS |
| Mallinckrodt Hospital Products Inc. | $16.48 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145104361 | CMS |
| Novartis Pharmaceuticals Corporation | $27.42 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087150362 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.